BCAS2 and Alzheimer disease: Thus, the impaired dendritic development in cKO mice further suggests that a lack of BCAS2 may cause neurodegenerative diseases, which supports previous reports of Alzheimer’s disease (AD) patients showing low mRNA expression of BCAS242.